Electric Bills Keep Rising

Since 2024, US power costs jumped 6.5%, and analysts warn another 8% nationwide rise by 2030. One small US stock could benefit as more households turn to backup storage.

AZN
Astrazeneca plc ADR
NASDAQ
85.9
Open 85.53 Prev Close 85.31
High 86.57 Low 85.45
Volume 3,358,175 Volume (Avg) 4,634
52 Week High 85.50 52 Week Low 60.83
Market Cap 266.3B PE Ratio 32.22

Shares Stats

Shares Outstanding3,101,090,000
Shares Float3,100,210,000
Shares Short7,740,000
Insider Holdings0%
Institution Holdings16.74%

About Astrazeneca plc ADR

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

General

NameAstrazeneca plc ADR
TickerAZN
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees94,300

Highlights

Analyst Target93.34
Market Cap266,333,000,000
PE Ratio32.22
PEG Ratio0.97
EBITDA19,128,000,512

Financials

Curr Year EPS Estimate4.57
Next Quarter EPS Estimate1.11
Profit Margin14.71%
Operating Margin21.13
Return on Assets0.08
Return on Equity0.20
Revenue56.6B
Earnings Per Share2.65
Revenue Per Share3.02
Gross Profit46,479,998,976
Quarterly Revenue Growth0.12

Valuation

Trailing PE32.19
Forward PE16.31
Price/Sales (Trailing 12 Mt.)4.70
Price/Book (Most Recent Quarter)5.80

Dividend

Astrazeneca plc ADR pays out a dividend of $1.63 per share, with a dividend yield of 1.89%.

AZN's last dividend payment was made to shareholders on September 8, 2025.

They pay out 66.95% of their earnings out as a dividend.

Recent Dividends

Sep 8, 2025$0.51
Mar 24, 2025$1.03
Sep 9, 2024$0.50
Mar 25, 2024$0.99
Most Popular

Lula asks Trump to lift 40% tariff on Brazilian imports

BRASILIA, Brazil (AP) — Brazilian President Luiz Inácio Lula da Silva asked U.S. President Donald Trump during a phone conversation Monday to lift imposed by the U.S. government on Brazilian imports.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Ken Griffin Slams Trump's 'Anti-American' And 'Nauseating' Tariff Policy: 'There's Only One Way This Game Ends'

Ken Griffin, a former supporter of President Donald Trump has publicly criticized the President’s tariff policy, calling it “anti-American.”

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Why was Jimmy Kimmel's late-night show suspended? Here's what we know

NEW YORK (AP) — ABC has pulled off the air, indefinitely — an unprecedented move that followed backlash from affiliated broadcasters and the head of the Federal Communications Commission over the comic's remarks about last week's killing of conservative activist .

A Market Set to Explode - Ad

By 2030, US energy storage is projected at $465 billion. That's nearly 75% growth. One small US stock is racing ahead of the curve with government programs and rising institutional backing.

Block CEO Jack Dorsey Invites Businesses Using Square PoS System To Test Bitcoin Payments Feature

Jack Dorsey, co-founder and CEO of Block Inc. (NYSE:XYZ), on Monday encouraged merchants using the company's Square platform to test Bitcoin (CRYPTO: BTC) payments.

Federal judge tosses Trump's $15B defamation lawsuit against New York Times

TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.

Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad

This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.

Move over, green lawns. Drier, warmer climate boosts interest in low-water landscaping

LITTLETON, Colo. (AP) — When Lena Astilli first bought her home outside of Denver, she had no interest in matching the wall-to-wall green lawns that dominated her block. She wanted native plants — the kind she remembered and loved as a child in New Mexico, that require far less water and have far more to offer insects and birds that are in decline.

Triple-Digit Growth in Energy Storage - Ad

The storage industry is growing fast, and one company is leading the charge with triple-digit revenue growth. With a market cap of only $177 million, the upside could be enormous.

Larry Ellison Topples Elon Musk As World's Richest, Then Loses $34 Billion In Days As Oracle-OpenAI Deal Sparks Market Doubts

Oracle co-founder Larry Ellison briefly surpassed Elon Musk as the world's richest person following a $101 billion overnight wealth surge. However, this was short-lived as his net worth plummeted by $34 billion in the days that followed.

The Underdog in a $465B Market - Ad

Tesla, Enphase, and Generac are household names. But the fastest upside rarely comes from the giants. A small US company with 200%+ growth is stepping into the spotlight.

Opendoor Stock Rallies On Expansion And Short Squeeze Hopes

Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.

It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant

ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.

Central Banks Demand More Gold - This $1 Firm Could Supply It - Ad

This tiny company is currently sitting on one of America's largest deposits of gold... land that was hidden away from the public for over 60 years. With Central Banks demanding gold to combat inflation - miners like this one show huge potential for investors

New England's shrimp industry is struggling, with fishermen catching few in 2025

PORTLAND, Maine (AP) — There's an effort underway to bring New England shrimp back to seafood customers — but fishermen have found few of the crustaceans, and the fishing industry that harvests them may face an even longer shutdown.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

Why Wall Street Could Be Late Again - Ad

The giants already proved the model. Tesla made $10 billion from storage last year. Enphase and Generac booked hundreds of millions. But a smaller US stock is showing even faster growth at a fraction of the size.

Bigger Returns With Less Capital? The Multiplier Strategy Explained - Ad

Instead of paying thousands for an ounce of gold, why not multiply your returns by investing in the companies that mine it? As gold prices climb, their profit margins can skyrocket - and so can their stock price. The gold multiplier effect means bigger profits with lower investment.

How 4 key infrastructure projects centered in Italy will reshape the European travel map

MILAN (AP) — Workers will begin drilling and blasting open the first tunnel connecting Austria to Italy under the Brenner Pass through the Alps on Thursday, marking a major milestone in a series of ambitious European Union projects that will accelerate passenger train travel between metropolitan centers and shift freight off the roads and onto rails.

Electric Bills Keep Rising - Ad

Since 2024, US power costs jumped 6.5%, and analysts warn another 8% nationwide rise by 2030. One small US stock could benefit as more households turn to backup storage.

FDA takes aim at Hims and other telehealth services in drug advertising blitz

WASHINGTON (AP) — For the first time, federal health officials are taking aim at promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the on pharmaceutical advertising.

AT&T attributes mass 911 outages in 3 states to fiber cuts made by 'third parties'

JACKSON, Miss. (AP) — Mass that swept across parts of Mississippi, Louisiana and Alabama on Thursday afternoon were caused by fiber cuts made by “third parties," according to a statement from AT&T.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

3 members of federal control board in Puerto Rico sue Trump and others for illegal firings

SAN JUAN, Puerto Rico (AP) — Three members of a federal control board overseeing Puerto Rico’s finances, by the administration of U.S. President Donald Trump, filed a lawsuit in federal court on Thursday alleging their firings were illegal.

A Market Set to Explode - Ad

By 2030, US energy storage is projected at $465 billion. That's nearly 75% growth. One small US stock is racing ahead of the curve with government programs and rising institutional backing.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service